Wall Street analysts predict Chipotle’s grim future. Facebook VP on mktng metrics. (RBDR 07.19.2016)

Today on RBDR:

1) Two Wall Street analysts reveal to investors what their proprietary survey research is foretelling what is ahead for the struggling Chipotle QSR.

2) Facebook VP of Advertising & Insights Brad Smallwood admits in a Journal of Advertising Research article that long-accepted, requested marketing metrics are not functional. Read the original report by clicking here.

RBDR is sponsored by Survey Sampling, whose website can deliver expertise in mobile & geo-targeting, respondent experiences, international research, B2B, brand tracking, CATI flexibility and end-to-end solutions. For more information, be sure to visit their website.

No need to spend time “searching” for today’s RBDR video. Subscribe to receive a FREE, personal email as soon as the new RBDR is uploaded. Click here.

J.D. Power for sale. Facebook member usage under scrutiny. (RBDR 11.6.2015)

Is YouTube blocked at your office? Access today’s RBDR in the RealPlayer Cloud by clicking here.

Today on RBDR:

1) McGraw Hill puts J.D. Power up for sale. Why is this happening and what is it worth?

2) Facebook 3rd quarter financials present revenues, profits and membership and usage figures that might concern marketers and market researchers who use those data.

Sponsored by Nuance, offering multi-language verbatim coding services to help companies quantify the meaning of open-ended answers. Nuance, a Decision Analyst company.
To find out more about Nuance, visit their website.

Don’t search for today’s RBDR! Receive an email, Monday-Thursday, with multiple links to the newest video as soon as it is uploaded. To subscribe, click here.

Apple iWatch’s HC info partners; HelloMD reworks MD-patient choices (PRVR–7-21-25/2014)

This week on Pharma Research VIDEO Report: 1) Apple’s iWatch — rumored to launch as early as October — with management team in place, and making impressive health care information partnerships.    2) Health startup HelloMD is recruiting top 1% of doctors and making them available to consumers who want to see the best and who are willing to pay cash for access.